"Georgios Gennimatas" General Hospital of Thessaloniki
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Koutelidakis, Ioannis M
BEYOND, NCT05304715 / 2021-005473-10: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Completed
2
44
Europe
Bezlotoxumab, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians., Normal saline 0.9% or 5% dextrose water, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians
Hellenic Institute for the Study of Sepsis
Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality
06/23
06/23
NCT04376203: Microbiome and Papillary Thyroid Microcarcinoma

Not yet recruiting
N/A
40
NA
Thyroidectomy
University of Ioannina
Papillary Thyroid Microcarcinoma, Microbiome
05/22
05/23
MYELO, NCT06292988: Predictive Factors for Medullary Thyroid Cancer Aggressiveness

Completed
N/A
500
Europe, US, RoW
Total Thyroidectomy
Aristotle University Of Thessaloniki
Medullary Thyroid Cancer
04/24
04/24
NCT06917755: The Impact of Immersive Virtual Reality Training in Thyroid Surgery

Recruiting
N/A
12
Europe
Virtual Reality Training in Thyroid Surgery, Convetional Training
G.Gennimatas General Hospital
Virtual Reality Simulation, Thyroid Surgery
04/25
05/25
Koutelidakis, Giannis
NCT06917755: The Impact of Immersive Virtual Reality Training in Thyroid Surgery

Recruiting
N/A
12
Europe
Virtual Reality Training in Thyroid Surgery, Convetional Training
G.Gennimatas General Hospital
Virtual Reality Simulation, Thyroid Surgery
04/25
05/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Koutelidakis, Ioannis M
BEYOND, NCT05304715 / 2021-005473-10: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Completed
2
44
Europe
Bezlotoxumab, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians., Normal saline 0.9% or 5% dextrose water, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians
Hellenic Institute for the Study of Sepsis
Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality
06/23
06/23
NCT04376203: Microbiome and Papillary Thyroid Microcarcinoma

Not yet recruiting
N/A
40
NA
Thyroidectomy
University of Ioannina
Papillary Thyroid Microcarcinoma, Microbiome
05/22
05/23
MYELO, NCT06292988: Predictive Factors for Medullary Thyroid Cancer Aggressiveness

Completed
N/A
500
Europe, US, RoW
Total Thyroidectomy
Aristotle University Of Thessaloniki
Medullary Thyroid Cancer
04/24
04/24
NCT06917755: The Impact of Immersive Virtual Reality Training in Thyroid Surgery

Recruiting
N/A
12
Europe
Virtual Reality Training in Thyroid Surgery, Convetional Training
G.Gennimatas General Hospital
Virtual Reality Simulation, Thyroid Surgery
04/25
05/25
Koutelidakis, Giannis
NCT06917755: The Impact of Immersive Virtual Reality Training in Thyroid Surgery

Recruiting
N/A
12
Europe
Virtual Reality Training in Thyroid Surgery, Convetional Training
G.Gennimatas General Hospital
Virtual Reality Simulation, Thyroid Surgery
04/25
05/25

Download Options